9 assets in Glucose Metabolism Disease

Therapeutic assets addressing Glucose Metabolism Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Metformin Glucose Metabolism Disease	SINA Health Education and Welfare Trust	P4	BBB (76)
Empagliflozin Glucose Metabolism Disease	SINA Health Education and Welfare Trust	P4	BB (69)
Ertugliflozin Glucose Metabolism Disease	Getz Pharma	P4	BB (65)
Liraglutide Glucose Metabolism Disease	RenJi Hospital	P3	BB (64)
FET Glucose Metabolism Disease	Rigshospitalet, Denmark	N/A	D (30)
Fludeoxyglucose Glucose Metabolism Disease	Rigshospitalet, Denmark	N/A	D (30)
Glucagon Glucose Metabolism Disease	Rigshospitalet, Denmark	N/A	D (30)
Semaglutide Glucose Metabolism Disease	RenJi Hospital	N/A	D (30)
Somatostatin Glucose Metabolism Disease	Rigshospitalet, Denmark	N/A	D (30)